Latest France News

Treasury Wine Estates has delivered a robust half-year performance with revenue climbing nearly 20% and profit surging 33%, driven by premiumisation and strategic acquisitions. The company also declared a higher interim dividend, signaling confidence in its growth trajectory.

CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.

Atlas Arteria reveals it will face a significant temporary supplemental tax under France’s new 2025 Finance Law, impacting its APRR Group operations with payments due late next year.

Domino's Pizza Enterprises signals a strategic reset with the closure of 205 underperforming stores, primarily in Japan, aiming to sharpen focus and improve profitability while maintaining steady earnings guidance.

IODM Limited reported a robust 49.4% increase in Q2 FY25 cash receipts, driven by explosive growth in its UK Education segment and strategic onboarding of prestigious universities.

Gas2Grid navigates regulatory headwinds in Australia by pursuing new petroleum ventures in the Philippines while contesting a significant legal claim in France. The company’s ASX suspension persists as it seeks to restore compliance through fresh contracts.

Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.

Apollo Minerals reports exceptional drilling results at its Salanie Gold Project in Gabon, revealing high-grade gold mineralisation and securing $1.25 million through a recent entitlement offer.

Medical Developments International has posted a robust improvement in operating cash flow and revenue for Q2 FY25, driven by higher demand and pricing for its flagship product Penthrox across Australia and Europe.

Atlas Arteria reports solid traffic and toll revenue growth in Q4 2024, led by strong light vehicle volumes and strategic toll increases across its global portfolio.

BrainChip Holdings reports a US$20 million cash balance and key defense contracts in its December 2024 quarterly update, underscoring its growing foothold in neuromorphic AI commercialization.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.